M. Vettoretti et al.: Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments. In: Transactions on Biomedical Engineering, 2018, 65, S. 1281 doi:10.1109/TBME.2017.2746340
R. M. Bergenstal, D. C. Klonoff, S. K. Garg, B. W. Bode, M. Meredith, R. H. Slover, A. J. Ahmann, J. B. Welsh, S. W. Lee, F. R. Kaufman: Threshold-based insulin-pump interruption for reduction of hypoglycemia. In: The New England Journal of Medicine, Band 369, Nummer 3, Juli 2013, S. 224–232, doi:10.1056/NEJMoa1303576, PMID 23789889.
T Spaic et al.: Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes. In: Diabetes Care, 2017 40(3), S. 359–366. doi:10.2337/dc16-1794.
Miller S et.al: Automatic learning algorithm for the MD-logic artificial pancreas system. In: Diabetes Technol Ther. Band13, Nr.10, 2011, doi:10.1089/dia.2010.0216.
Boris Kovatchev et al.: Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm. In: Diabetes Technology and Therapeutics. Januar 2024, doi:10.1089/dia.2023.0469.
E. C. Cobry et al.: Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. In: DiabetesTechnology & Therapeutics, 2021; doi:10.1089/dia.2020.0532
A C van Bon et al.: Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands. In: Lancet Digit Health. Band6, 2024, S.e272–80, doi:10.1016/S2589-7500(24)00002-5.
Bauw H. et al. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial; Diabetes Care 2021;44:836–838 | https://doi.org/10.2337/dc20-2106
Dana Lewis, Scott Leibrand, #OpenAPS Community: Real-World Use of Open Source Artificial Pancreas Systems. In: Journal of Diabetes Science and Technology. Band10, Nr.6, November 2016, ISSN1932-2968, S.1411–1411, doi:10.1177/1932296816665635, PMID 27510442.
K.Braune et al.: Why #WeAreNotWaiting – Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. In: J Med Internet Res., 2021, 23(6), S. e25409; jmir.org/2021/6/e25409 doi:10.2196/25409
Martin Tauschmann et al.: Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. In: The Lancet, 2018, 392, S. 1321–1329; doi:10.1016/S0140-6736(18)31947-0
Pierre Yves Benhamou et al.: Customization of home closed loop insulin delivery in adult patients with type 1 diabetes. In: Acta Diabetologica, 2018, 55, S. 549–556; doi:10.1007/s00592-018-1123-1
S. K. Garg et al.: Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. In: Diabetes Technology & Therapeutics, 2017, 19; doi:10.1089/dia.2016.0421
E. Isganaitis et al.: Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults. In: Diabetes Technology and Therapeutics, 2020; doi:10.1089/dia.2020.0572
Sue A. Brown et al., Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes, Diabetes Care 2021, Band 44, Nummer 7, doi:10.2337/dc21-0172.
van Veldhuisen et al.: Bihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy, JAMA Surg. 2022;157(10) Doi:10.1001/jamasurg.2022.3702
G.Krutkyte et al.: Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery; DIABETES TECHNOLOGY & THERAPEUTICS 25(3), 2023 DOI:10.1089/dia.2022.0400
R. M. Bergenstal, D. C. Klonoff, S. K. Garg, B. W. Bode, M. Meredith, R. H. Slover, A. J. Ahmann, J. B. Welsh, S. W. Lee, F. R. Kaufman: Threshold-based insulin-pump interruption for reduction of hypoglycemia. In: The New England Journal of Medicine, Band 369, Nummer 3, Juli 2013, S. 224–232, doi:10.1056/NEJMoa1303576, PMID 23789889.
Dana Lewis, Scott Leibrand, #OpenAPS Community: Real-World Use of Open Source Artificial Pancreas Systems. In: Journal of Diabetes Science and Technology. Band10, Nr.6, November 2016, ISSN1932-2968, S.1411–1411, doi:10.1177/1932296816665635, PMID 27510442.
Dana Lewis, Scott Leibrand, #OpenAPS Community: Real-World Use of Open Source Artificial Pancreas Systems. In: Journal of Diabetes Science and Technology. Band10, Nr.6, November 2016, ISSN1932-2968, S.1411–1411, doi:10.1177/1932296816665635, PMID 27510442.
